NO20034704L - Anvendelse av sjeldne jordforbindelser for forhindring av nyrestensykdom - Google Patents

Anvendelse av sjeldne jordforbindelser for forhindring av nyrestensykdom

Info

Publication number: NO20034704L
Authority: NO; Norway
Prior art keywords: oxalate; rare earth; lanthanum carbonate; adjusted; buffer
Prior art date: 2001-04-23

Application number

NO20034704A

Other languages

English (en)

Norwegian (no)

Other versions

NO20034704D0 (no

Inventor

Michael J Abrams

J Gary Bridger

Simon P Fricker

Stefan R Idzan

Original Assignee

Anormed Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-23

Filing date

2003-10-21

Publication date

2003-11-25

2003-10-21 Application filed by Anormed Inc filed Critical Anormed Inc

2003-10-21 Publication of NO20034704D0 publication Critical patent/NO20034704D0/no

2003-11-25 Publication of NO20034704L publication Critical patent/NO20034704L/no

Links

229910052761 rare earth metal Inorganic materials 0.000 title abstract 2
208000000913 Kidney Calculi Diseases 0.000 title 1
206010029148 Nephrolithiasis Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
-1 rare earth compounds Chemical class 0.000 title 1
229910017569 La2(CO3)3 Inorganic materials 0.000 abstract 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 3
NZPIUJUFIFZSPW-UHFFFAOYSA-H lanthanum carbonate Chemical compound [La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O NZPIUJUFIFZSPW-UHFFFAOYSA-H 0.000 abstract 3
229960001633 lanthanum carbonate Drugs 0.000 abstract 3
229940039748 oxalate Drugs 0.000 abstract 3
229910019142 PO4 Inorganic materials 0.000 abstract 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
239000010452 phosphate Substances 0.000 abstract 2
150000002910 rare earth metals Chemical class 0.000 abstract 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
238000003556 assay Methods 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000011574 phosphorus Substances 0.000 abstract 1
229910052698 phosphorus Inorganic materials 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1
ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 abstract 1
229940039790 sodium oxalate Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
External Artificial Organs (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20034704A 2001-04-23 2003-10-21 Anvendelse av sjeldne jordforbindelser for forhindring av nyrestensykdom NO20034704L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28590101P	2001-04-23	2001-04-23
PCT/US2002/013000 WO2002085348A1 (en)	2001-04-23	2002-04-22	Use of rare earth compounds for the prevention of kidney stone disease

Publications (2)

Publication Number	Publication Date
NO20034704D0 NO20034704D0 (no)	2003-10-21
NO20034704L true NO20034704L (no)	2003-11-25

Family

ID=23096166

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034704A NO20034704L (no)	2001-04-23	2003-10-21	Anvendelse av sjeldne jordforbindelser for forhindring av nyrestensykdom

Country Status (25)

Country	Link
US (2)	US7192609B2 (cs)
EP (1)	EP1389102B1 (cs)
JP (2)	JP4515030B2 (cs)
KR (1)	KR100956013B1 (cs)
CN (1)	CN100438866C (cs)
AT (1)	ATE499943T1 (cs)
AU (2)	AU2002307543B2 (cs)
BR (1)	BR0209072A (cs)
CA (1)	CA2442414C (cs)
CY (1)	CY1112049T1 (cs)
CZ (2)	CZ17802U1 (cs)
DE (2)	DE20221760U1 (cs)
DK (2)	DK1389102T3 (cs)
ES (1)	ES2362271T3 (cs)
FI (1)	FIU20060390U0 (cs)
HU (1)	HUP0303938A3 (cs)
MX (1)	MXPA03009668A (cs)
NO (1)	NO20034704L (cs)
NZ (1)	NZ528818A (cs)
PL (1)	PL370642A1 (cs)
PT (1)	PT1389102E (cs)
RU (1)	RU2296584C2 (cs)
SI (1)	SI1389102T1 (cs)
WO (1)	WO2002085348A1 (cs)
ZA (1)	ZA200308112B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1660104B1 (en) *	2003-08-26	2010-03-10	Shire Holdings AG	Pharmaceutical formulation comprising lanthanum compounds
US7381428B2 (en) *	2003-08-26	2008-06-03	Shire International Licensing B.V.	Stabilized lanthanum carbonate compositions
KR20070054191A (ko) *	2004-07-27	2007-05-28	샤이어 파마세우티컬, 인크.	란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법
US20070104799A1 (en) *	2005-11-09	2007-05-10	Shire International Licensing B.V.	Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
WO2009118760A2 (en) *	2008-03-26	2009-10-01	Matrix Laboratories Limited	Lanthanum composition
ES2871021T3 (es) *	2010-05-12	2021-10-28	Spectrum Pharmaceuticals Inc	Hidróxido de carbonato de lantano, oxicarbonato de lantano y procedimientos de fabricación y uso
RU2657755C1 (ru) *	2017-07-10	2018-06-15	Александр Александрович Кролевец	Способ получения нанокапсул солей лантаноидов в каррагинане
WO2021101461A1 (en)	2019-11-21	2021-05-27	Santa Farma İlaç Sanayi̇ A.Ş.	Oral solid pharmaceutical compositions comprising lanthanum carbonate octahydrate
WO2021163574A1 (en) *	2020-02-13	2021-08-19	Lawrence Livermore National Security, Llc	Methods of sequestering target elements
JP2025521859A (ja) *	2022-07-01	2025-07-10	エイエムジーエムティー	経口投与可能な医薬剤形および高シュウ酸尿症の治療方法におけるその使用
AU2023424695A1 (en) *	2023-01-18	2025-08-28	Applause Pharma Co., Ltd.	Pharmaceutical composition having, as active ingredient, cerium compound that contains trivalent cerium

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1668562C3 (de) *	1967-12-08	1975-01-30	Pharmazeutische Fabrik Evers & Co, 2080 Pinneberg	Cergluconat, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Präparate
DE3213139A1 (de) *	1980-12-11	1983-10-20	Leskovar, Peter, Dr.-Ing., 8000 München	Harnsteinaufloesende mittel
DE3046580A1 (de) *	1980-12-11	1982-07-01	Leskovar, Peter, Dr.-Ing., 8000 München	Harnsteinaufloesende mittel
JPS614528A (ja)	1984-06-15	1986-01-10	Arubatsuku Service Kk	水溶性ガスの高純度溶液の製造装置
JPS614529A (ja) *	1984-06-15	1986-01-10	Asahi Chem Ind Co Ltd	リン酸イオンの吸着剤
JPH06705B2 (ja) *	1985-12-19	1994-01-05	旭化成工業株式会社	リン酸イオンの固定化剤
US5171583A (en) *	1988-10-21	1992-12-15	The Regents Of The University Of California	Treatment of osteoporosis using potassium bicarbonate
US5696239A (en) *	1988-10-31	1997-12-09	The Dow Chemical Company	Conjugates possessing ortho ligating functionality and complexes thereof
US5342604A (en) *	1988-10-31	1994-08-30	The Dow Chemical Company	Complexes possessing ortho ligating functionality
CA2117351C (en) *	1992-01-13	1998-03-03	Julian Belknap Lo	Preparation of tablets of increased strength
RU2061040C1 (ru) *	1994-05-23	1996-05-27	Акционерное общество "Русский йогурт"	Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для получения препаратов и продуктов питания для профилактики и лечения гипероксалурии
US5562921A (en) *	1994-07-15	1996-10-08	Sherman; Bernard C.	Stable solid pharmaceutical compositions containing enalapril maleate
GB9506126D0 (en)	1995-03-25	1995-05-10	Johnson Matthey Plc	Pharmaceutical composition and method
US5951958A (en) *	1996-07-10	1999-09-14	Shin-Etsu Chemical Co., Ltd.	Method for the preparation of rare earth phosphate of low overstoichiometric phosphorous content
US5902825A (en) *	1997-01-07	1999-05-11	Mitreoak, Ltd.	Composition and method for the palliation of pain associated with diseases of the bone and bone joints
US6355242B1 (en)	1997-05-23	2002-03-12	Ixion Biotechnology, Inc.	Materials and methods for treating or preventing oxalate-related disease
JP4996780B2 (ja)	1997-05-23	2012-08-08	オクセラインコーポレイテッド	シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
US5985938A (en)	1997-11-05	1999-11-16	Geltex Pharmaceuticals, Inc.	Method for reducing oxalate
US20010014352A1 (en) *	1998-05-27	2001-08-16	Udit Batra	Compressed tablet formulation
US6160016A (en) *	1999-12-22	2000-12-12	Wisconsin Alumni Research Foundation	Phosphorus binder
WO2004030669A1 (en) *	2002-09-30	2004-04-15	Schering Corporation	Use of tricyclic amides for the treatment of disorders of calcium homeostasis
EP1660104B1 (en) *	2003-08-26	2010-03-10	Shire Holdings AG	Pharmaceutical formulation comprising lanthanum compounds

2002
- 2002-04-22 KR KR1020037013813A patent/KR100956013B1/ko not_active Expired - Fee Related
- 2002-04-22 SI SI200230944T patent/SI1389102T1/sl unknown
- 2002-04-22 AT AT02764336T patent/ATE499943T1/de active
- 2002-04-22 AU AU2002307543A patent/AU2002307543B2/en not_active Ceased
- 2002-04-22 PT PT02764336T patent/PT1389102E/pt unknown
- 2002-04-22 DE DE20221760U patent/DE20221760U1/de not_active Expired - Lifetime
- 2002-04-22 NZ NZ528818A patent/NZ528818A/en unknown
- 2002-04-22 US US10/128,783 patent/US7192609B2/en not_active Expired - Fee Related
- 2002-04-22 CZ CZ200718489U patent/CZ17802U1/cs not_active IP Right Cessation
- 2002-04-22 DK DK02764336.0T patent/DK1389102T3/da active
- 2002-04-22 CN CNB028085574A patent/CN100438866C/zh not_active Expired - Fee Related
- 2002-04-22 RU RU2003133991/14A patent/RU2296584C2/ru not_active IP Right Cessation
- 2002-04-22 ES ES02764336T patent/ES2362271T3/es not_active Expired - Lifetime
- 2002-04-22 PL PL02370642A patent/PL370642A1/xx unknown
- 2002-04-22 DE DE60239329T patent/DE60239329D1/de not_active Expired - Lifetime
- 2002-04-22 WO PCT/US2002/013000 patent/WO2002085348A1/en not_active Ceased
- 2002-04-22 CZ CZ20032880A patent/CZ298280B6/cs not_active IP Right Cessation
- 2002-04-22 JP JP2002582921A patent/JP4515030B2/ja not_active Expired - Fee Related
- 2002-04-22 HU HU0303938A patent/HUP0303938A3/hu unknown
- 2002-04-22 EP EP02764336A patent/EP1389102B1/en not_active Expired - Lifetime
- 2002-04-22 CA CA2442414A patent/CA2442414C/en not_active Expired - Fee Related
- 2002-04-22 MX MXPA03009668A patent/MXPA03009668A/es active IP Right Grant
- 2002-04-22 BR BR0209072-4A patent/BR0209072A/pt not_active IP Right Cessation
2003
- 2003-10-17 ZA ZA200308112A patent/ZA200308112B/en unknown
- 2003-10-21 NO NO20034704A patent/NO20034704L/no not_active Application Discontinuation
2006
- 2006-07-18 AU AU2006203055A patent/AU2006203055B2/en not_active Ceased
- 2006-09-22 FI FI20060390U patent/FIU20060390U0/fi not_active Application Discontinuation
- 2006-09-26 DK DK200600251U patent/DK200600251U4/da not_active IP Right Cessation
- 2006-10-05 US US11/538,926 patent/US20070116782A1/en not_active Abandoned
2009
- 2009-05-13 JP JP2009116718A patent/JP2009173684A/ja not_active Withdrawn
2011
- 2011-05-04 CY CY20111100432T patent/CY1112049T1/el unknown

Also Published As

Publication number	Publication date
BR0209072A (pt)	2006-02-07
RU2296584C2 (ru)	2007-04-10
WO2002085348A1 (en)	2002-10-31
NO20034704D0 (no)	2003-10-21
HUP0303938A3 (en)	2012-09-28
DE60239329D1 (de)	2011-04-14
DK200600251U4 (da)	2007-12-28
RU2003133991A (ru)	2005-04-20
US7192609B2 (en)	2007-03-20
HUP0303938A2 (hu)	2004-04-28
CA2442414A1 (en)	2002-10-31
EP1389102B1 (en)	2011-03-02
ATE499943T1 (de)	2011-03-15
KR100956013B1 (ko)	2010-05-06
DK200600251U1 (da)	2007-01-12
EP1389102A1 (en)	2004-02-18
CN1503668A (zh)	2004-06-09
MXPA03009668A (es)	2004-02-12
KR20040018362A (ko)	2004-03-03
JP2005507369A (ja)	2005-03-17
CZ20032880A3 (cs)	2004-01-14
PL370642A1 (en)	2005-05-30
US20020155168A1 (en)	2002-10-24
JP4515030B2 (ja)	2010-07-28
DK1389102T3 (da)	2011-06-06
AU2006203055A1 (en)	2006-08-10
CZ17802U1 (cs)	2007-09-03
CZ298280B6 (cs)	2007-08-15
PT1389102E (pt)	2011-06-07
SI1389102T1 (sl)	2011-07-29
ES2362271T3 (es)	2011-06-30
US20070116782A1 (en)	2007-05-24
AU2006203055B2 (en)	2008-12-18
CA2442414C (en)	2011-02-01
FIU20060390U0 (fi)	2006-09-22
CY1112049T1 (el)	2015-11-04
HK1064030A1 (en)	2005-01-21
DE20221760U1 (de)	2007-08-16
ZA200308112B (en)	2005-01-17
NZ528818A (en)	2008-09-26
CN100438866C (zh)	2008-12-03
AU2002307543B2 (en)	2006-04-27
JP2009173684A (ja)	2009-08-06
EP1389102A4 (en)	2004-07-14

Legal Events

Date	Code	Title	Description
2012-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20034704D0 (no)	2003-10-21	Anvendelse av sjeldne jordforbindelser for forhindring av nyrestensykdom
DE60232017D1 (de)	2009-05-28	Flüssige zusammensetzung aus faktor vii polypeptiden
NO20025819L (no)	2001-05-16	Natriumsalt og kontrastmiddel inneholdende dette
ATE367429T1 (de)	2007-08-15	Stabilisierte saure chlorbleichmittelzusammensetzung und verfahren zur anwendung
BR0212652A (pt)	2004-08-24	Composição para o tratamento de uma formação subterrânea, método de tratamento de uma formação subterrânea para aumentar a permeabilidade, e método de tratamento de um conjunto de escoramento numa fratura numa formação subterrânea para aumentar a sua permeabilidade
ATE218802T1 (de)	2002-06-15	Spüllösung für organe und gewebe
ATE547114T1 (de)	2012-03-15	Flüssige zusammensetzungen von factor vii polypeptiden
ATE470147T1 (de)	2010-06-15	Verfahren und mittel zur bestimmung von gesamthärte
BR0014389A (pt)	2002-10-29	Compostos de ligação metálica e seus usos
ATE254950T1 (de)	2003-12-15	Verfahren zur reinigung wässriger pufferlösungen
DE69908554D1 (de)	2003-07-10	Verfahren zur reinigung eines sauren gases
IT8447751A0 (it)	1984-02-24	Composizione contenente polisaccaride per legare proteine specifiche, metodo per ottenerla e procedimento nonche' corredo di saggio che la impiegano
RU95117286A (ru)	1998-01-10	Ирригационный раствор для офтальмологических операций
BR9814933A (pt)	2001-01-30	Composto, composicao farmaceutica e metodo de tratamento de infeccao por hiv.
Rodionova et al.	2002	Ca2+-activator of the luminescence system of the earthworms Henlea sp.,(Annelida: Clitellata: Oligochaeta: Enchytraeidae)
KR950032287A (ko)	1995-12-20	단백질 c의 분해를 저해하는 방법
JP2001255332A5 (cs)	2007-04-05
EA199900710A1 (ru)	2000-04-24	Кристаллическая гидратированная натриевая соль (е)-4,6-дихлор-3-(2-оксо-1-фенилпирролидин-3-илиденметил)-1н-индол-2-карбоновой кислоты
DK1369122T3 (da)	2007-09-17	Anticancermiddel
DE60224839D1 (de)	2008-03-13	Verfahren zur lagerung von tetrazoliumverbindungen, dafür bestimmter stabilisator und nach dem verfahren aufbewahrte tetrazoliumverbindungsreagenz lösung
ATE439136T1 (de)	2009-08-15	Verfahren zur behandlung von halitose
RU2003120703A (ru)	2005-02-20	Способ регенерации костной ткани в эксперименте
RU2003117105A (ru)	2005-02-10	Состав для обработки материалов
RU99100562A (ru)	1999-06-20	Способ крепления стенок скважин
RU2004113966A (ru)	2005-10-27	Способ повышения эффективности дезинфицирующего средства